Benjamin Halladay, CFO: Esperion Therapeutics ESPR Sell · Filed 25/12/18

Trade details

Type: Insider sale
Amount: $26,926.79
Shares · price: 7,337 sh · $3.67 a share
Held after: 467,525 sh
Stock: Esperion Therapeutics ESPR
Person: Benjamin HalladayCFO
Trade date: 25/12/17
Filed: 25/12/18
Days to filing: 1 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Esperion Therapeutics trades, last 26 weeks

What else happened in Esperion Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/17~01/16

Benjamin Halladay's recent trades

Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$34K
10,773 sh
$34K
Filed 06/18
Traded 06/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$17.4K
6,424 sh
$17.4K
Filed 03/18
Traded 03/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$19.8K
7,046 sh
$19.8K
Filed 25/09/18
Traded 25/09/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$12
11 sh
$12
Filed 25/07/18
Traded 25/07/17
Benjamin HalladayCFO
SellEsperion Therapeutics
Sell
Esperion Therapeutics
ESPR
$8,313
7,229 sh
$8,313
Filed 25/06/18
Traded 25/06/17

Benjamin Halladay, CFO — sold $26.9K of Esperion Therapeutics ESPR · 1.5% of holdings | Whalegun